| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697902 | Clinical Oncology | 2016 | 7 Pages |
Abstract
The increased numbers of patients being treated with IMRT has meant that there have been significant changes in the way that quality assurance is carried out. These have been mainly in the reduction of measurements and the increase in software-based verification. However, quality assurance is still a significant burden and still has an effect on the numbers of patients who can be treated with IMRT.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
F. Abolaban, S. Zaman, J. Cashmore, A. Nisbet, C.H. Clark,